Parabilis Medicines, Inc. (PBLS) shareholders
Close on Nov 17, 2026Market cap $3.49BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Rajeev Shah Joint filing with RA Capital Management, L.P. (23.80%), Peter Kolchinsky (23.80%) and 1 more | 28,933,371 | 23.80% | 13D (active) | Jun 11, 2026 |
| FMR LLC Joint filing with Abigail P. Johnson (8.50%) | 10,292,735 | 8.50% | 13G (passive) | Jun 30, 2026 |
| Steven Gillis Joint filing with ARCH Venture Fund XII, L.P. (5.30%), ARCH Venture Partners XII, L.P. (5.30%) and 4 more | 6,412,780 | 5.30% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PBLS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 28,933,371 | 23.42% | $791.91M | New | 6.88% |
| FMR LLC | 10,292,735 | 8.33% | $281.71M | New | 0.01% |
| ARCH Venture Management, LLC | 6,412,780 | 5.19% | $175.52M | New | 15.95% |
| venBio Partners LLC | 5,266,697 | 4.26% | $144.15M | New | 27.75% |
| Alphabet Inc. | 4,919,498 | 3.98% | $134.65M | New | 0.14% |
| Nextech Invest, Ltd. | 4,663,176 | 3.77% | $127.63M | New | 6.06% |
| Cormorant Asset Management, LP | 4,615,612 | 3.74% | $126.33M | New | 6.47% |
| Regeneron Pharmaceuticals, Inc. | 4,166,666 | 3.37% | $114.04M | New | 64.35% |
| Siren, L.L.C. | 2,992,259 | 2.42% | $81.90M | New | 1.66% |
| Farallon Capital Management LLC | 2,368,200 | 1.92% | $64.82M | New | 0.30% |
| Jupiter Topco LLC | 2,296,547 | 1.86% | $62.71M | New | 0.03% |
| Frazier Life Sciences Management, L.P. | 1,920,805 | 1.55% | $52.57M | New | 1.14% |
| Deerfield Management Company, L.P. (Series C) | 1,880,704 | 1.52% | $51.47M | New | 0.54% |
| General Catalyst Group Management, LLC | 1,600,937 | 1.30% | $43.82M | New | 23.24% |
| General Atlantic, L.P. | 1,538,461 | 1.25% | $42.11M | New | 1.45% |
| Soleus Capital Management, L.P. | 1,465,070 | 1.19% | $40.10M | New | 1.38% |
| Vanguard Portfolio Management LLC | 1,302,479 | 1.05% | $35.65M | New | 0.00% |
| Vanguard Capital Management LLC | 1,156,962 | 0.94% | $31.67M | New | 0.00% |
| JPMorgan Chase & Co | 1,042,772 | 0.84% | $30.44M | New | 0.00% |
| Foresite Capital Management VI LLC | 999,044 | 0.81% | $27.34M | New | 4.26% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 79 | 99M | 80.1% | 79 / 0 | 0 / 0 | 99M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of PBLS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1,121,000 | 0.91% | $30.68M | 0.00% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 807,764 | 0.65% | $22.11M | 0.01% | Jun 30, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 486,669 | 0.39% | $13.32M | 0.11% | Jun 30, 2026 |
| JPMorgan Small Cap Growth Fund | 480,209 | 0.39% | $13.14M | 0.50% | Jun 30, 2026 |
| AB Small Cap Growth Portfolio | 329,809 | 0.27% | $9.03M | 0.29% | Jun 30, 2026 |
| Janus Henderson Global Life Sciences Fund | 313,255 | 0.25% | $8.57M | 0.15% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 255,694 | 0.21% | $7.00M | 0.01% | Jun 30, 2026 |
| Vanguard Small-Cap Growth Index Fund | 239,759 | 0.19% | $6.56M | 0.01% | Jun 30, 2026 |
| Franklin Small Cap Growth Fund | 156,411 | 0.13% | $5.31M | 0.22% | Jul 31, 2026 |
| JPMorgan Small Cap Blend Fund | 154,583 | 0.13% | $4.23M | 0.25% | Jun 30, 2026 |
| Federated Hermes Kaufmann Fund | 151,500 | 0.12% | $5.15M | 0.10% | Jul 31, 2026 |
| Small Cap Core Portfolio | 128,992 | 0.10% | $3.53M | 0.41% | Jun 30, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 119,911 | 0.10% | $3.28M | 0.02% | Jun 30, 2026 |
| SmallCap Growth Fund I | 100,169 | 0.08% | $3.40M | 0.14% | Jul 31, 2026 |
| Franklin Biotechnology Discovery Fund | 93,010 | 0.08% | $3.16M | 0.27% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Mathai Mammen | President & CEO, Director | – | – | Jun 9, 2026 |
| Teresa Jurgensen | General Counsel | – | – | Jun 9, 2026 |
| Helen Huei-in Ho | See Remarks | – | – | Jun 9, 2026 |
| Mohammed Fawzi Benzaghou | Chief Medical Officer | – | – | Jun 9, 2026 |
| Rohin Mhatre | See Remarks | – | – | Jun 9, 2026 |
| Thomas Rodolpho Kotarakos | Chief Financial Officer | – | – | Jun 9, 2026 |
| Craig Tendler | Director | – | – | Aug 25, 2026 |
| Capital Healthcare Fund LP RA | Director, 10% owner | – | – | Jul 22, 2026 |
| Rajeev M. Shah | Director, 10% owner | – | – | Jul 22, 2026 |
| RA Capital Nexus Fund III, L.P. | Director | 6,556,740 | 5.31% | Jul 22, 2026 |
| Peter Kolchinsky | Director, 10% owner | – | – | Jul 22, 2026 |
| Ra Capital Management, L.P. | Director, 10% owner | 26,529,686 | 21.48% | Jul 22, 2026 |
| Alan Sebulsky | Director | 25,935 | 0.02% | Jun 16, 2026 |
| Edward M. Fitzgerald | Director | 14,688 | 0.01% | Jun 15, 2026 |
| Alexis Borisy | Director | 105,414 | 0.09% | Jun 15, 2026 |
| Richard Klausner | Director | – | – | Jun 11, 2026 |
| Barbara Weber | Director | – | – | Jun 11, 2026 |
| Jake Simson | Director | – | – | Jun 11, 2026 |
| Krishna Yeshwant | Director | – | – | Jun 11, 2026 |
| Soleus Capital Master Fund, L.P. | 10% owner | – | – | Jun 29, 2026 |
| Soleus PE GP III, LLC | 10% owner | – | – | Jun 29, 2026 |
| Soleus Capital, LLC | 10% owner | – | – | Jun 29, 2026 |
| Soleus GP, LLC | 10% owner | – | – | Jun 29, 2026 |
| Soleus Private Equity Fund III, L.P. | 10% owner | – | – | Jun 29, 2026 |
| Soleus Capital Management, L.P. | 10% owner | – | – | Jun 29, 2026 |
| Soleus Capital Group, LLC | 10% owner | 1,027,000 | 0.83% | Jun 29, 2026 |
| Soleus Private Equity GP III, LLC | 10% owner | – | – | Jun 29, 2026 |
| Guy Levy | 10% owner | – | – | Jun 29, 2026 |
| Deerfield Mgmt III, L.P. | 10% owner | – | – | Jun 11, 2026 |
| Deerfield Management Company, L.P. | 10% owner | – | – | Jun 11, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. Director, 10% owner | Jul 22, 2026 | Buy | +47,250 | $29.77 | $1.41M | 26,529,686 |
| Ra Capital Management, L.P. Director, 10% owner | Jul 21, 2026 | Buy | +37,723 | $30.00 | $1.13M | 26,482,436 |
| Ra Capital Management, L.P. Director, 10% owner | Jul 21, 2026 | Buy | +6,504 | $29.17 | $189.72K | 26,444,713 |
| Ra Capital Management, L.P. Director, 10% owner | Jul 21, 2026 | Buy | +21,696 | $27.96 | $606.62K | 26,438,209 |
| Ra Capital Management, L.P. Director, 10% owner | Jul 20, 2026 | Buy | +98,433 | $27.13 | $2.67M | 26,383,526 |
| Ra Capital Management, L.P. Director, 10% owner | Jul 20, 2026 | Buy | +32,987 | $27.72 | $914.40K | 26,416,513 |
| Alan Sebulsky Director | Jun 15, 2026 | Buy | +5,000 | $26.00 | $130.00K | 25,935 |
| Alan Sebulsky Director | Jun 15, 2026 | Buy | +4,065 | $27.10 | $110.16K | 30,000 |
| Alan Sebulsky Director | Jun 12, 2026 | Buy | +8,435 | $27.67 | $233.40K | 20,935 |
| Soleus Capital Group, LLC 10% owner | Jun 11, 2026 | Buy | +375,000 | $20.00 | $7.50M | 1,027,000 |
| Soleus Capital Group, LLC 10% owner | Jun 11, 2026 | Conversion | +527,070 | $9.48 | $5.00M | 527,070 |
| Soleus Capital Group, LLC 10% owner | Jun 11, 2026 | Buy | +125,000 | $20.00 | $2.50M | 652,000 |
| Alexis Borisy Director | Jun 11, 2026 | Conversion | +105,414 | – | – | 105,414 |
| RA Capital Nexus Fund III, L.P. Director | Jun 11, 2026 | Conversion | +6,556,740 | – | – | 6,556,740 |
| RA Capital Nexus Fund III, L.P. Director | Jun 11, 2026 | Conversion | +1,187,881 | – | – | 1,187,881 |
| RA Capital Nexus Fund III, L.P. Director | Jun 11, 2026 | Buy | +1,460,397 | $20.00 | $29.21M | 2,648,278 |
| RA Capital Nexus Fund III, L.P. Director | Jun 11, 2026 | Buy | +19,728,353 | $20.00 | $394.57M | 26,285,093 |
| Alan Sebulsky Director | Jun 11, 2026 | Buy | +12,500 | $20.00 | $250.00K | 12,500 |
| Edward M. Fitzgerald Director | Jun 11, 2026 | Conversion | +5,271 | – | – | 14,688 |
| Edward M. Fitzgerald Director | Jun 11, 2026 | Conversion | +3,878 | – | – | 9,417 |
| Edward M. Fitzgerald Director | Jun 11, 2026 | Conversion | +5,539 | – | – | 5,539 |
| Deerfield Mgmt HIF, L.P. 10% owner | Jun 11, 2026 | Conversion | +149,238 | – | – | 272,228 |
| Deerfield Mgmt HIF, L.P. 10% owner | Jun 11, 2026 | Conversion | +122,990 | – | – | 122,990 |
| Deerfield Mgmt HIF, L.P. 10% owner | Jun 11, 2026 | Conversion | +122,990 | – | – | 122,990 |
| Deerfield Mgmt HIF, L.P. 10% owner | Jun 11, 2026 | Conversion | +149,238 | – | – | 272,228 |
| Deerfield Mgmt HIF, L.P. 10% owner | Jun 11, 2026 | Conversion | +260,992 | – | – | 533,220 |
| Deerfield Mgmt HIF, L.P. 10% owner | Jun 11, 2026 | Conversion | +260,992 | – | – | 533,220 |
| Deerfield Mgmt HIF, L.P. 10% owner | Jun 11, 2026 | Conversion | +407,132 | – | – | 940,352 |
| Deerfield Mgmt HIF, L.P. 10% owner | Jun 11, 2026 | Conversion | +407,132 | – | – | 940,352 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 5 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Parabilis Medicines's stock actually held short. Settlement fails (shares not delivered on time) peaked at 105,755 shares on Sep 21, 2026 over the last 90 days.
See a number that looks wrong?